Tissue engineering through autologous mesenchymal stem cells
- 31 October 2004
- journal article
- review article
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 15 (5) , 406-410
- https://doi.org/10.1016/j.copbio.2004.08.003
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Wnt-7a Causes Loss of Differentiated Phenotype and Inhibits Apoptosis of Articular Chondrocytes via Different MechanismsJournal of Biological Chemistry, 2004
- Cell Shape, Cytoskeletal Tension, and RhoA Regulate Stem Cell Lineage CommitmentDevelopmental Cell, 2004
- Short‐Term BMP‐2 Expression Is Sufficient for In Vivo Osteochondral Differentiation of Mesenchymal Stem CellsThe International Journal of Cell Cloning, 2004
- The role of bone in the treatment of osteoarthritis11Supported by Procter & Gamble Pharmaceuticals, Mason, OHOsteoarthritis and Cartilage, 2004
- Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitorNature Medicine, 2003
- The Wnt Signaling Inhibitor Dickkopf-1 Is Required for Reentry into the Cell Cycle of Human Adult Stem Cells from Bone MarrowJournal of Biological Chemistry, 2003
- Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stromaProceedings of the National Academy of Sciences, 2003
- A unified model for the action of leptin on bone turnoverJournal of Cellular Biochemistry, 2003
- Adipogenesis and aging: does aging make fat go MAD?Experimental Gerontology, 2002
- Blockade of endogenous interleukin 12 results in suppression of murine streptococcal cell wall arthritis by enhancement of interleukin 10 and interleukin 1RaAnnals of the Rheumatic Diseases, 2000